denotes an abstract that is clinically relevant.
denotes that this is a recommended PHD Trainee Session.
denotes that this is a ticketed session.
Program: Education Program
Session: Myelodysplastic Syndromes: What We Have and What We Want
Hematology Disease Topics & Pathways:
Diseases, Bone Marrow Failure, Elderly, MDS, Biological Processes, Study Population, Myeloid Malignancies, genomics, Clinically relevant, immune mechanism, inflammation, microenvironment, molecular interactions
Session: Myelodysplastic Syndromes: What We Have and What We Want
Hematology Disease Topics & Pathways:
Diseases, Bone Marrow Failure, Elderly, MDS, Biological Processes, Study Population, Myeloid Malignancies, genomics, Clinically relevant, immune mechanism, inflammation, microenvironment, molecular interactions
Saturday, December 5, 2020, 9:25 AM-9:30 AM
Disclosures: Platzbecker: Amgen: Honoraria, Research Funding; Bergenbio: Research Funding; JAZZ: Honoraria, Research Funding; Janssen: Honoraria, Research Funding; Novartis: Honoraria, Research Funding; BMS: Honoraria, Research Funding.
See more of: Myelodysplastic Syndromes: What We Have and What We Want
See more of: Education Program
See more of: Education Program
Previous Presentation
|
Next Presentation >>